Amusing that Regulus is entering the HCV arena. You probably know that Kleanthis Xanthopoulos was the CEO of ANDS who departed under a cloud only two weeks before ANDS disclosed that its lead drug had bombed (#msg-11589918).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”